Evidence of cerebellar TDP-43 loss of function in FTLD-TDP

被引:0
|
作者
Sarah Pickles
Tania F. Gendron
Yuka Koike
Mei Yue
Yuping Song
Jennifer M. Kachergus
J. Shi
Michael DeTure
E. Aubrey Thompson
Björn Oskarsson
Neill R. Graff-Radford
Bradley F. Boeve
Ronald C. Petersen
Zbigniew K. Wszolek
Keith A. Josephs
Dennis W. Dickson
Leonard Petrucelli
Casey N. Cook
Mercedes Prudencio
机构
[1] Mayo Clinic,Department of Neuroscience
[2] Mayo Clinic Graduate School of Biomedical Sciences,Department of Cancer Biology
[3] Mayo Clinic,Department of Neurology
[4] Mayo Clinic,Department of Neurology
[5] Mayo Clinic,undefined
关键词
Cerebellum; Frontotemporal lobar degeneration; Stathmin-2; TDP-43;
D O I
暂无
中图分类号
学科分类号
摘要
Frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) is a neurodegenerative disease primarily affecting the frontal and/or temporal cortices. However, a growing body of evidence suggests that the cerebellum contributes to biochemical, cognitive, and behavioral changes in FTLD-TDP. To evaluate cerebellar TDP-43 expression and function in FTLD-TDP, we analyzed TDP-43 protein levels and the splicing of a TDP-43 target, STMN2, in the cerebellum of 95 FTLD-TDP cases and 25 non-neurological disease controls. Soluble TDP-43 was decreased in the cerebellum of FTLD-TDP cases but a concomitant increase in insoluble TDP-43 was not seen. Truncated STMN2 transcripts, an indicator of TDP-43 dysfunction, were elevated in the cerebellum of FTLD-TDP cases and inversely associated with TDP-43 levels. Additionally, lower cerebellar TDP-43 associated with a younger age at disease onset. We provide evidence of TDP-43 loss of function in the cerebellum in FTLD-TDP, supporting further investigation into this understudied brain region.
引用
收藏
相关论文
共 50 条
  • [31] Antibody against TDP-43 phosphorylated at serine 369 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes (vol 140, pg 645, 2020)
    Neumann, Manuela
    Frick, Petra
    Paron, Francesca
    Kosten, Jonas
    Buratti, Emanuele
    Mackenzie, Ian R.
    ACTA NEUROPATHOLOGICA, 2021, 141 (01) : 137 - 137
  • [32] The role of TDP-43 in the pathogenesis of ALS and FTLD
    Baralle, Marco
    Buratti, Emanuele
    Baralle, Francisco E.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2013, 41 : 1536 - 1540
  • [33] TDP-43 pathology in FTLD-subtypes
    Nishihira, Yasushi
    Mao, Qinwen
    Kohler, Missia
    Coppola, Giovanni
    Rademakers, Rosa
    Rademaker, Alfred
    Weintraub, Sandra
    Mesula, M-Marsel
    Geula, Changiz
    Bigio, Eileen H.
    BRAIN PATHOLOGY, 2019, 29 : 80 - 80
  • [34] Loss of TDP-43 function underlies hippocampal and cortical synaptic deficits in TDP-43 proteinopathies
    Jiangxia Ni
    Yongfei Ren
    Tonghui Su
    Jia Zhou
    Chaoying Fu
    Yi Lu
    De’an Li
    Jing Zhao
    Yunxia Li
    Yaoyang Zhang
    Yanshan Fang
    Nan Liu
    Yang Geng
    Yelin Chen
    Molecular Psychiatry, 2023, 28 : 931 - 945
  • [35] Ubiquitinated TDP-43 is associated with FTLD and ALS
    Nature Clinical Practice Neurology, 2007, 3 (1): : 7 - 8
  • [36] C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation
    Keith A. Josephs
    Yong-Jie Zhang
    Matthew Baker
    Rosa Rademakers
    Leonard Petrucelli
    Dennis W. Dickson
    Acta Neuropathologica Communications, 7
  • [37] Expression Analysis of Metallothionein Ie and IIa in FTLD-TDP With ALS, FTLD-TDP, and Alzheimer Disease
    Mishra, Manjari
    Scarella, Timothy
    Bigio, Eileen
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2010, 69 (05): : 542 - 542
  • [38] Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders
    Tibor Hortobágyi
    Claire Troakes
    Agnes L. Nishimura
    Caroline Vance
    John C. van Swieten
    Harro Seelaar
    Andrew King
    Safa Al-Sarraj
    Boris Rogelj
    Christopher E. Shaw
    Acta Neuropathologica, 2011, 121 : 519 - 527
  • [39] Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders
    Hortobagyi, Tibor
    Troakes, Claire
    Nishimura, Agnes L.
    Vance, Caroline
    van Swieten, John C.
    Seelaar, Harro
    King, Andrew
    Al-Sarraj, Safa
    Rogelj, Boris
    Shaw, Christopher E.
    ACTA NEUROPATHOLOGICA, 2011, 121 (04) : 519 - 527
  • [40] Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid
    Bigio, Eileen H.
    Wu, Jane Y.
    Deng, Han-Xiang
    Bit-Ivan, Esther N.
    Mao, Qinwen
    Ganti, Rakhee
    Peterson, Melanie
    Siddique, Nailah
    Geula, Changiz
    Siddique, Teepu
    Mesulam, Marsel
    ACTA NEUROPATHOLOGICA, 2013, 125 (03) : 463 - 465